Company news
MiMedx Group, Inc news in 2021
MiMedx Group, Inc's news releases, calls and decks from 2021, newest first.
MIMEDX to Present at the 40th Annual J.P. Morgan Healthcare Conference
December 21, 2021
MIMEDX Outlines Long-Term Value Creation Strategy at Virtual Investor Day
December 6, 2021
MIMEDX Announces Speakers for December 7 Investor Day
November 29, 2021
MIMEDX to Present at the Piper Sandler 33rd Annual Healthcare Conference
November 21, 2021
Peer Reviewed Study Demonstrates MIMEDX Dehydrated Human Amnion Chorion Membrane (dHACM) Outperforms Standard of Care in Select Mohs Defect Reconstructions
November 16, 2021
MIMEDX Announces Third Quarter 2021 Operating and Financial Results
November 1, 2021
Two New Studies Demonstrate in vitro Bioactivity Potential of Micronized Dehydrated Human Amnion Chorion Membrane (mdHACM) to Prevent Pathological Processes Underlying Osteoarthritis (OA) and Tendinopathy
October 31, 2021
MIMEDX to Host Third Quarter 2021 Operating and Financial Results Conference Call on November 3
October 19, 2021
MIMEDX to Host Virtual Investor Day on December 7, 2021
October 13, 2021
MIMEDX Reports Top-line Data from Two Late-Stage Musculoskeletal Trials with Proprietary Amniotic Tissue Technology
September 12, 2021
MIMEDX Announces Effectiveness of Shelf Registration Statement
September 7, 2021
MIMEDX to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
September 6, 2021
MIMEDX Announces Filing of Shelf Registration Statement with Securities and Exchange Commission
August 26, 2021
Medicare Data: Significant Reductions in Amputations, Emergency Visits, and Hospital Readmissions Associated with Advanced Treatment Using Skin Substitute Products for Lower Extremity Diabetic Ulcers (LEDUs)
August 16, 2021
MIMEDX Promotes Marion Snyder to Chief of Staff, Senior Vice President, Government Affairs
August 11, 2021
MIMEDX Announces Second Quarter 2021 Operating and Financial Results
August 2, 2021
MIMEDX to Host Second Quarter 2021 Operating and Financial Results Conference Call on August 4
July 19, 2021
MIMEDX Joins Russell 3000® and 2000® Indexes
June 27, 2021
MIMEDX to Present at the Raymond James 2021 Human Health Innovation Conference
June 15, 2021
New Study Demonstrates Potential for MIMEDX Purion® Processed Dehydrated Human Amnion/Chorion Membrane to Modulate Pathological Scar Tissue Formation
June 14, 2021
MIMEDX Receives Regulatory Approval to Commercialize EPIFIX® in Japan
June 7, 2021
MIMEDX to Participate at the Jefferies Virtual Healthcare Conference
May 26, 2021
MIMEDX Reminds Shareholders to Pre-Register for the Upcoming Virtual 2021 Annual Meeting of Shareholders
May 24, 2021
MIMEDX Reminds Shareholders to Vote at the Upcoming Annual Meeting
May 11, 2021
MIMEDX Announces Collaborative Agreement with the Wake Forest Institute for Regenerative Medicine
May 5, 2021
MIMEDX Urges Shareholders to Consider Prescience Point’s Motivations Before Voting Their Shares at the Company’s Annual Meeting
May 3, 2021
MIMEDX Files Definitive Proxy Materials and Mails Letter to Shareholders Highlighting Actions Taken to Transform MIMEDX and Drive Significant Value for Shareholders
May 2, 2021
MiMedx Welcomes Dirk Stevens, Ph.D., as Senior Vice President, Quality Assurance and Regulatory Affairs
April 27, 2021
MiMedx Announces First Quarter 2021 Financial and Operating Results
April 27, 2021
MiMedx to Host First Quarter 2021 Operating and Financial Results Conference Call on April 29
April 21, 2021
MiMedx Announces Last Patients Last Visits in Three Late-Stage Musculoskeletal Trials with Proprietary Tissue Technology
April 18, 2021
MiMedx Confirms Receipt of Director Nominations from Prescience Point Capital Management
April 15, 2021
MiMedx Awarded Amniotic Tissue Supplier Agreement with Premier® Inc.’s SURPASS™ Purchasing Program
March 29, 2021
MiMedx Announces Fourth Quarter and Full Year 2020 Financial and Operating Results
March 7, 2021
MiMedx Announces Appointment of Phyllis Gardner, M.D. to Board of Directors
March 7, 2021
MiMedx to Participate at Upcoming Investor Conferences
March 2, 2021
MiMedx to Host Fourth Quarter and Full Year 2020 Operating and Financial Results Conference Call on March 9
March 1, 2021
MiMedx to Participate at the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
February 9, 2021
Reminder: MiMedx to Present at the 39th Annual J.P. Morgan Healthcare Conference
January 5, 2021
MiMedx to Participate at the H.C. Wainwright BioConnect 2021 Conference
January 3, 2021
Calls in 2021
Decks in 2021
- Investor Day (December 2021)
Investor day · 95 slides · Dec 7, 2021
- Piper Sandler 33rd Annual Healthcare Conference 2021
Conference · 18 slides · Nov 22, 2021
- Investor Presentation (September 2021)
Investor deck · 21 slides · Sep 13, 2021
- Raymond James Human Health Innovation Conference 2021
Conference · 25 slides · Jun 23, 2021
- Bank of America Securities 2021 Virtual Healthcare Conference
Conference · 7 slides · May 12, 2021
- Proxy Contest (May 2021)
Proxy contest · 48 slides · May 7, 2021
- Proxy Contest (May 2021)
Proxy contest · 42 slides · May 4, 2021
- 2021 H.C. Wainwright & Co. Global Life Sciences Conference
Conference · 22 slides · Mar 10, 2021
- 2021 J.P. Morgan 39th Annual Healthcare Conference
Conference · 42 slides · Jan 11, 2021